Prophylactic migraine therapy: emerging treatment options.
In this paper, new treatment options for migraine prevention are reviewed. An overview about migraine pathophysiology is provided and current indications for migraine prevention and new and upcoming preventive medications are discussed briefly. Data are presented on topiramate, levetiracetam, zonisamide, botulinim toxin, tizanidine, nefazodone, lisinopril, candesartan, carabersat, petasites, and coenzyme Q.
Bigal
Marcelo E
ME
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA. mbigal@aecom.yu.edu
Krymchantowski
Abouch V
AV
Rapoport
Alan M
AM
D002491:Central Nervous System Agents / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000503:physiopathology / Q000517:prevention & control*; D020011:Protective Agents / Q000627:therapeutic use*
D002491:Central Nervous System Agents; D020011:Protective Agents